Skip to content

    Recently Viewed


      African Doctors

      Why Johnson & Johnson has made it a mission to improve surgical care in Africa

      As the G4 Alliance plans to discuss safe and affordable surgical care at the 70th annual World Health Assembly this week, a leader at the company, fresh off a trip to the continent, shares why it’s a topic that resonates at Johnson & Johnson.

      Share Article
      share to

      A few weeks ago, I had the unique privilege of traveling to Africa to meet with Johnson & Johnson employees, government officials and other stakeholders in Accra, Ghana, and Johannesburg, South Africa.

      While I travel frequently, it is always a great experience to see the work of our international employees and partners firsthand, and to see our company Credo in action. My visit to one of those partners, the Medical & Surgical Skills Institute (MSSI) in Ghana, was one of the highlights of my trip.

      Suturing class

      Participants in a suturing class in Ghana

      According to data from Vanderbilt University Medical Center, 5 billion people—particularly in low-income and lower-middle-income countries—lack access to safe, affordable surgical and anesthesia care. And while Ghana, on average, does better than most countries in making surgery available to people who need it, it’s always crucial to keep training new health workers to help maintain the skills of people working in surgical settings.

      In fact, ensuring that more people around the world have access to essential surgical care is a major component of Johnson & Johnson’s commitment to the 2030 UN Sustainable Development Goals.

      To date, more than 10,500 healthcare providers have received critical skills training from MSSI, which gets supplies and funding from Johnson & Johnson.

      A commitment to help improve surgical training in Africa

      For more than 10 years, the company has partnered with MSSI to provide life-saving surgical training to doctors, nurses and other healthcare providers in Ghana and throughout sub-Saharan Africa. To date, more than 10,500 healthcare providers have received critical skills training from MSSI, which gets supplies and funding from Johnson & Johnson.

      During my visit, I was able to observe a suturing class for nurses and midwives who came from all over Ghana, including many rural areas outside the capital of Accra. Their commitment to learning was clear: They were excited to improve their skills in a hospital setting, and looked forward to returning home to better serve their patients and share what they’d mastered alongside other nurses and midwives.

      All over the world, the Credo is a force for good, driving us to ensure we make a difference in the communities in which we work around the world. My trip confirmed for me that Johnson & Johnson has an exciting opportunity to grow in sub-Saharan Africa and meet the significant burgeoning surgical—and overall healthcare—needs there for years to come.

      More from Johnson & Johnson

      Blue latex-gloved hands holding a beaker filled with yellow liquid

      IBD rates are rising in communities of color. Can these innovators help?

      Scientists aren’t sure what’s behind the upward trend. That’s why Johnson & Johnson Innovation put out the call to address this troubling health disparity.
      DNA illustration genetic material

      Harnessing the human genome is the future of healthcare—and Johnson & Johnson is helping lead the way

      The company’s partnership with the largest human genome sequencing project in the world will increase scientists’ understanding of genetic diseases and help create new interventions. Here, a look at the breakthroughs that have guided the understanding of the power of DNA.
      Health & wellness
      1123 BTN-Lung Cancer-Iede2.jpg
      Health & wellness

      By the numbers: Who gets lung cancer?

      Each year, more people die of lung cancer than colon, breast and prostate cancers combined. Learn how Johnson & Johnson is dedicated to improving outcomes by integrating the company’s MedTech and Innovative Medicine expertise.
      You are now leaving and going to a site with a different privacy policy. Please click below to continue to that site.